RELAFEN 750 Pill - beige oval, 19mm
Generic Name: nabumetone
Pill with imprint RELAFEN 750 is Beige, Oval and has been identified as Relafen 750 mg. It is supplied by GlaxoSmithKline.
Relafen is used in the treatment of Osteoarthritis; Rheumatoid Arthritis and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Risk cannot be ruled out during pregnancy. Relafen 750 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RELAFEN 750
Relafen
- Generic Name
- nabumetone
- Imprint
- RELAFEN 750
- Strength
- 750 mg
- Color
- Beige
- Size
- 19.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Nonsteroidal anti-inflammatory drugs
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- National Drug Code (NDC)
- 00029-4852 (Discontinued)
More about Relafen (nabumetone)
- Check interactions
- Compare alternatives
- Reviews (38)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: Nonsteroidal anti-inflammatory drugs
- Breastfeeding
- En español
Patient resources
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.